AstraZeneca Aktie
142,70
EUR
+0,60
EUR
+0,42
%
120,00
GBP
+0,72
GBP
+0,60
%
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 105,00 GBP | - | 13.09.2024 | |
| Goldman Sachs Group Inc. | 159,14 GBP | - | 10.09.2024 | |
| UBS AG | 113,00 GBP | - | 09.09.2024 | |
| JP Morgan Chase & Co. | 140,00 GBP | - | 09.09.2024 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 150,00 GBP | - | 03.09.2024 | |
| DZ BANK | - | - | 26.07.2024 | |
| Jefferies & Company Inc. | 117,00 GBP | - | 25.07.2024 | |
| Barclays Capital | 135,00 GBP | - | 24.06.2024 | |
| Bernstein Research | 177,00 GBP | - | 24.04.2024 |
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 2 | 2 | 137,02 GBP | - |
| Bayer | 1 | 9 | 0 | 31,89 EUR | +19,82% |
| BioNTech (ADRs) | 0 | 4 | 1 | 94,60 USD | -25,51% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 1 | 0 | - | - |
| EVOTEC SE | 3 | 1 | 1 | 11,60 EUR | +87,10% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 6 | 1 | 0 | 186,50 EUR | +11,18% |
| Moderna Inc | 2 | 1 | 1 | 142,25 USD | +104,94% |
| Novartis AG | 3 | 6 | 1 | 99,56 CHF | +1,12% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 3 | 3 | 0 | 31,40 USD | +5,44% |
| Roche AG (Genussschein) | 2 | 5 | 3 | 267,56 CHF | +1,08% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 2 | 1 | 107,00 EUR | +3,90% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |